Hikma Pharmaceuticals (HKMPY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    OTC: HKMPY · Real-Time Price · USD
    49.25
    -0.15 (-0.30%)
    At close: Oct 03, 2025, 12:19 PM
    49.25
    0.00%
    Pre-market: Oct 03, 2025, 09:44 AM EDT

    Hikma Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 455M 281M 233M 544M
    Depreciation & Amortization
    		 197M 198M 193M 145M
    Stock-Based Compensation
    		 27M 25M 22M 29M
    Other Working Capital
    		 43M 131M -49M 84M
    Other Non-Cash Items
    		 20M 24M 213M 39M
    Deferred Income Tax
    		 n/a n/a n/a -89M
    Change in Working Capital
    		 -135M 80M -131M -30M
    Operating Cash Flow
    		 564M 608M 530M 638M
    Capital Expenditures
    		 -235M -204M -225M -229M
    Cash Acquisitions
    		 -162M -105M -380M -17M
    Purchase of Investments
    		 -2M -27M -15M -3M
    Sales Maturities Of Investments
    		 n/a 1M n/a 6M
    Other Investing Acitivies
    		 -52M -33M 13M 5M
    Investing Cash Flow
    		 -381M -333M -607M -238M
    Debt Repayment
    		 124M -93M 456M -83M
    Common Stock Repurchased
    		 n/a n/a -300M n/a
    Dividend Paid
    		 -175M -137M -125M -120M
    Other Financial Acitivies
    		 -99M -107M -89M -84M
    Financial Cash Flow
    		 -188M -337M -58M -287M
    Net Cash Flow
    		 -17M -65M -156M 103M
    Free Cash Flow
    		 329M 404M 305M 409M

    Add to Watchlist